| DISTINGUISHED SPEAKERS |
| |
Nagi G. Ayad
Associate Professor, Psychiatry & Behavioral Sciences
University of Miami, Epigenetix |
| |
Thomas Chan
Chief Scientific Officer, Discovery and Early Development
ArQule |
| |
Thomas G. Diacovo
Director, Neonatal and Critical Care Research
Associate Professor of Pediatrics and Pathology and Cell Biology
Columbia University |
| |
Daniel L. Flynn
President & CEO
Deciphera Pharmaceuticals |
| |
Lyn H. Jones
Senior Director, Head of Chemical Biology & Rare Diseases Chemistry
Pfizer |
| |
Soumya Ray
Assistant Professor of Neurology & Biochemistry
Harvard University |
| |
Wai Leong Tam
Senior Post Doc in Bob Weinberg's Lab
Whitehead Institute |
| |
Yibing Shan
Senior Scientist
D. E. Shaw Research |
| |
| Advisory Board Members Helping to Organize the Event |
| |
Thomas Chan
Chief Scientific Officer, Discovery and Early Development
ArQule |
| |
Alexei Degterev
Assistant Professor
Tufts University |
| |
Marcie Glicksman
Senior Director Leads Discovery
Harvard |
| |
Min Liu
Assistant Director, the Laboratory of Drug Discovery
Brigham and Women's Hospital |
| |
Richard Luke
Cancer and Infection Research Area
(fomerly AstraZeneca) |
| |
Jeffrey Simard
Scientist, Lead Discovery
Amgen |
| |
Graham Smith
Group Leader, Medicinal Chemistry
Merck |